Patient Experience Defines the Future: The Evolution of Nasal Products in Upper Respiratory Conditions

Guenter Nadler, Director of Business Development for Allergic Rhinitis and Cough & Cold Solutions at Aptar Pharma, will take the audience on a journey through the evolution of topical nasal drug delivery, from traditional remedies and the first registered nasal spray product to today's advanced patient-centric solutions. The presentation will explore how decades of innovation in formulations, delivery technologies, and device design have continuously advanced nasal drug delivery landscape and transformed the patient experience.

The presentation will reveal why the next chapter of innovation is no longer defined by functionality alone. In a market increasingly driven by consumer expectations and self-directed healthcare decisions, patient experience has become a powerful differentiator. Through the case studies of Otrivin® and PureHale®, Guenter will demonstrate how Aptar Pharma identifies unmet needs and translates them into meaningful product experiences that enhance usability, comfort, and adherence.

The session will conclude with Aptar Pharma's vision for future innovation and illustrate how Aptar Pharma´s capabilities support customers in turning ideas into winning products in their journey from formulation to patient.